Globe Life (NYSE:GL) Hits New 52-Week High on Analyst Upgrade

Globe Life Inc. (NYSE:GL) shares hit a new 52-week high during mid-day trading on Thursday after Truist Financial raised their price target on the stock from $158.00 to $180.00. Truist Financial currently has a buy rating on the stock. Globe Life traded as high as $152.71 and last traded at $149.7130, with a volume of 172918 shares trading hands. The stock had previously closed at $144.82.

A number of other equities research analysts have also recently commented on the stock. Morgan Stanley reissued an “overweight” rating and set a $176.00 target price on shares of Globe Life in a research report on Monday, December 15th. Keefe, Bruyette & Woods increased their price objective on Globe Life from $160.00 to $162.00 and gave the company an “outperform” rating in a report on Tuesday, October 28th. Wells Fargo & Company dropped their target price on Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research note on Friday, October 24th. Weiss Ratings cut Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday, January 14th. Finally, Evercore lowered Globe Life from an “outperform” rating to an “in-line” rating and set a $155.00 price target on the stock. in a research note on Tuesday, January 6th. Seven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $171.00.

Insider Buying and Selling at Globe Life

In other news, CEO Frank M. Svoboda sold 9,379 shares of the stock in a transaction dated Tuesday, December 16th. The stock was sold at an average price of $140.43, for a total value of $1,317,092.97. Following the transaction, the chief executive officer directly owned 35,868 shares of the company’s stock, valued at approximately $5,036,943.24. This represents a 20.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.51% of the company’s stock.

Hedge Funds Weigh In On Globe Life

Institutional investors have recently modified their holdings of the stock. Transcend Capital Advisors LLC boosted its stake in shares of Globe Life by 3.9% in the fourth quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock worth $317,000 after buying an additional 84 shares during the last quarter. Natural Investments LLC lifted its holdings in Globe Life by 2.6% in the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after acquiring an additional 87 shares during the period. Intech Investment Management LLC grew its stake in shares of Globe Life by 0.8% during the 2nd quarter. Intech Investment Management LLC now owns 11,572 shares of the company’s stock worth $1,438,000 after purchasing an additional 95 shares during the period. CX Institutional grew its stake in shares of Globe Life by 5.6% during the 3rd quarter. CX Institutional now owns 1,805 shares of the company’s stock worth $258,000 after purchasing an additional 96 shares during the period. Finally, Laird Norton Wetherby Wealth Management LLC increased its holdings in shares of Globe Life by 2.2% during the 3rd quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,518 shares of the company’s stock valued at $646,000 after purchasing an additional 99 shares in the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Globe Life Stock Performance

The firm’s 50 day moving average is $139.38 and its 200-day moving average is $137.97. The stock has a market capitalization of $11.67 billion, a price-to-earnings ratio of 10.41 and a beta of 0.47. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The firm had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the prior year, the business posted $3.14 EPS. The firm’s quarterly revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Analysts forecast that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.